Oklahoma Defense Industry Association
  • Member Access
    • Member Login
    • Member Directory
  • About Us
    • Who is ODIA >
      • History
    • Our Leadership >
      • Our Team
      • Board of Directors
    • Public Policy + Advocacy
  • News + Events
    • Industry News
    • Ops Watch
    • Events Calendar
    • ODIA News
  • Engage With Us
    • Ways to Engage >
      • Membership >
        • Member Level Overview
        • Membership Applications >
          • Membership Application - Corporation
          • Membership Application - Individual
      • Sponsor Opportunities >
        • Overwatch Partner
        • Event Sponsor
      • Contact Us
  • Resources
    • Oklahoma's Military Installations
    • Department of Defense Key Leadership
  • Contact Us

Ops Watch

Weekly Grant Opportunities Update - August 23, 2021

8/28/2021

0 Comments

 
Picture
Department of Defense
Department of the Air Force
  • AFRL Kirtland AFB - Science, Innovation and Technology Partnership Intermediary Agreement

Department of Army - USAMRAA
  • DOD Melanoma, Discovery Award
  • DOD Neurofibromatosis, Clinical Trial Consortium Award

Department of Navy - Office of Naval Research
  • FY2022 Vannevar Bush Faculty Fellowship (VBFF) Program  

Department of Defense
Department of the Air Force

AFRL Kirtland AFB - Science, Innovation and Technology Partnership Intermediary Agreement


Proposal Due Date:                                                  September 21, 2021
Expected Number of Awards:                                1
Estimated Total Program Funding:                      $75,000,000
Award Ceiling:                                                           $55,000,000
Award Floor:                                                                      
Funding Opportunity Number:                              PIA-FOA-21-AFRL-0001

Purpose: The DoD Air Force Research Laboratory (AFRL) at Kirtland Air Force Base, New Mexico, is seeking applications under Funding Opportunity Announcement (FOA) entitled “Science, Innovation and Technology Partnership Intermediary Agreement”.

The Government is seeking to enter into five-year Partnership Intermediary Agreements (PIAs) with entities that facilitate joint projects and accelerate technology transfer between the lab and the commercial market. These intermediaries help companies to identify federal technologies that can be licensed and commercialized. They also work to increase the likelihood of successful cooperative activities between the lab, small businesses, academia and industry.
Under the future FOA, some the objectives will include, but may not be limited to: 
  • Patent and intellectual property (IP) management
  • Technology and market research
  • Collaboration spaces and business incubation
  • Technology assessment activities
  • Prototyping and manufacturing capabilities

https://www.grants.gov/web/grants/view-opportunity.html?oppId=333566


Department of Defense
Department of the Army

USAMRAA – DOD Melanoma, Discovery Award


Pre-Application Submission Deadline:                  October 20, 2021
Proposal Due Date:                                                    November 10, 2021
Expected Number of Awards:                                  1
Estimated Total Program Funding:                        $3,200,000
Award Ceiling:                                                                   
Award Floor:                                                                      
Funding Opportunity Number:                               W81XWH-21-MRP-DA

Purpose: The FY21 MRP Discovery Award supports innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications in melanoma research. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation regarding an important question for melanoma research and/or patient community. The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design. Preliminary data are not required. If preliminary data is presented it will be evaluated for its support of the specific aims, objectives, and/or hypothesis.

Innovation is a key characteristic of this funding opportunity. Innovative research may introduce a new paradigm, look at existing problems from new perspectives, or exhibit other highly creative qualities. Research that represents an incremental advancement on previously published work is not considered innovative.

The following list, although not all-inclusive, provides examples of research that is not innovative:
  • Using a published series of in vitro assays to further characterize a model system
  • Incorporating known biomarkers into in vivo or clinical models of the disease or condition
  • Investigating the next logical step or continuation of a previous research project
  • Proposing work that is an incremental advancement of published data   

Inclusion of preliminary data is not required but is allowed. The strength of the proposed research should be based on sound scientific rationale and logical reasoning. The presentation of substantial preliminary data suggests that the proposed research project would be more appropriately submitted to a different award mechanism. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects. Absence of preliminary data will not negatively affect scientific peer or programmatic review of the application. All data presented will be subject to evaluation.

Early career investigators, including postdoctoral fellows (or equivalent), are encouraged to be named by the organization as the Principal Investigator (PI) on the application.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=335364


Department of Defense
Department of the Army

USAMRAA – DOD Neurofibromatosis, Clinical Trial Consortium Award


Pre-Application Submission Deadline:                  September 17, 2021
Proposal Due Date:                                                    October 29, 2021
Expected Number of Awards:                                  1
Estimated Total Program Funding:                         $25,000,000
Award Ceiling:                                                                   
Award Floor:                                                                      
Funding Opportunity Number:                                W81XWH-21-NFRP-CTCA

Purpose: The NFRP Clinical Trial Consortium Award mechanism was first offered in FY06, and subsequently in FY11 and FY16, with awards being made as grants or cooperative agreements. This FY21 research announcement is being offered through a different type of award mechanism, a Research Other Transaction Award (rOTA) under the authority of 10 USC 2371.

The FY21 NFRP Clinical Trial Consortium Award is intended to support a major goal/product-driven consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic NF research and ultimately decrease the impact of the disease. The objectives of the rOTA are the conception, design, development, and conduct of collaborative Phase I and II clinical evaluations of promising therapeutic agents for the management or treatment of NF1, NF2, and schwannomatosis.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=335360


Department of Defense
Department of the Navy

Office of Naval Research
FY2022 Vannevar Bush Faculty Fellowship (VBFF) Program


Proposal Due Date:                                                     February 4, 2022
Expected Number of Awards:                                   10
Estimated Total Program Funding:                         $24,000,000
Award Ceiling:                                                              $3,000,000
Award Floor:                                                                 $0
Funding Opportunity Number:                                N00014-21-S-F007

Purpose: Before World War I, Dr. Vannevar Bush (1890-1974) was a professor and Dean of Engineering at the Massachusetts Institute of Technology and founded a large defense and electronics company. He was a forward-thinking policymaker who, during World War II, went on to serve as the director of the U.S. Defense Department’s Office of Scientific Research and Development, coordinating the work of thousands of scientists in the service of ending the war. In his 1945 report to the President of the United States, Science, “The Endless Frontier”, Bush called for an expansion of government support for science, and he pressed for the creation of the National Science Foundation (NSF). Dr. Bush was concerned about how the scientific research supported by the Department of Defense (DoD) during WWII could be sustained with a focus on peacetime goals. He believed that basic research was “the pacemaker of technological progress”. “New products and new processes do not appear full-grown”, Bush wrote. “They are founded on new principles and new conceptions, which in turn are painstakingly developed by research in the purest realms of science”.

Dr. Bush’s life work embodies the spirit of this research program, formerly known as the National Security Science and Engineering Faculty Fellowship (NSSEFF). Therefore, in his in his honor, the name was changed to the Vannevar Bush Faculty Fellowship (VBFF) program (https://www.defense.gov/News/Article/Article/955536/dod-debuts-vannevar-bush-faculty-fellowship).

Please see full opportunity announcement attached for additional information and instructions.
​

https://www.grants.gov/web/grants/view-opportunity.html?oppId=335368
Picture
0 Comments



Leave a Reply.

    About

    RFIs, Meeting Notices, Proposers/Industry Days, Nominations

    Archives

    October 2021
    September 2021
    August 2021

    Categories

    All

    RSS Feed

Copyright Oklahoma Defense Industry Association.  All Rights Reserved.
PO Box 2082 | Oklahoma City, OK 73101   
Phone: +01 - 405 406 2104 | info@oklahomadefense.com
Picture
  • Member Access
    • Member Login
    • Member Directory
  • About Us
    • Who is ODIA >
      • History
    • Our Leadership >
      • Our Team
      • Board of Directors
    • Public Policy + Advocacy
  • News + Events
    • Industry News
    • Ops Watch
    • Events Calendar
    • ODIA News
  • Engage With Us
    • Ways to Engage >
      • Membership >
        • Member Level Overview
        • Membership Applications >
          • Membership Application - Corporation
          • Membership Application - Individual
      • Sponsor Opportunities >
        • Overwatch Partner
        • Event Sponsor
      • Contact Us
  • Resources
    • Oklahoma's Military Installations
    • Department of Defense Key Leadership
  • Contact Us